MedPath

Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of Nodule Allocation.

Conditions
Thyroid Goitre
Thyroid Nodule
Thyroid Diseases
Registration Number
NCT03128255
Lead Sponsor
Jena University Hospital
Brief Summary

Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • patients with thyroidal nodules,
  • euthyroidism
  • Uptake >0,5% on Tc-99m-pertechnetate- scintigraphy
Exclusion Criteria
  • thyroid medications in the last 6 months
  • Iodine exposition in the last 6 months
  • thyroid surgery or radioiodine therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metabolic-sonographic nodule allocation1 year

The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Jena

🇩🇪

Jena, Thuringia, Germany

University Hospital Jena
🇩🇪Jena, Thuringia, Germany
Martin Freesmeyer, Dr.med.
Contact
+49 3641 9-329805
martin.freesmeyer@med.uni-jena.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.